Sotio (Czechia)

Recent papers from Sotio (Czechia)

1. From established biology to candidate archetypes in high-grade serous ovarian carcinoma: the ARCHETYPE-PX evidence framework and consensus method2026
2. Nationwide Implementation of Neoadjuvant Nivolumab-Based Chemo-Immunotherapy for Resectable NSCLC: Surgical Outcomes from a Prospective Multicenter StudyAnnals of Surgical Oncology · 2026
3. SOT102, a novel CLDN18.2-targeting antibody-drug conjugate, exhibits strong therapeutic potential in solid tumorsBMC Cancer · 2026
4. The immune microenvironment of HPV-associated cancers: from viral oncogenesis to immunotherapy responseSHILAP Revista de lepidopterología · 2026
5. Multiomics immune profiling of a patient-relevant orthotopic lung cancer model using SEPARATE-SeqNature Communications · 2026
6. NKG2A inhibition promotes NK cell-CD8+ T cell interactions to improve anticancer immunity in ovarian carcinomaNature Communications · 2026
7. Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancernpj Precision Oncology · 2026
8. Ovarian cancer metastasis to the human omentum disrupts organ homeostasis and induces fundamental tissue reprogrammingNature Communications · 2025
9. High Treg and PMN-MDSC densities are a hallmark of tertiary lymphoid structures in fatal cases of cervical cancer.2025
10. Novel PD-1-targeted, activity-optimized IL-15 mutein SOT201 acting in cis provides antitumor activity superior to PD1-IL2vJournal for ImmunoTherapy of Cancer · 2025
11. Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patientsCancer Cell · 2025
12. Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancersCell Reports Medicine · 2025
13. Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor–positive mammary carcinogenesisJNCI Journal of the National Cancer Institute · 2024
14. Immunogenic properties of nickel-doped maghemite nanoparticles and the implication for cancer immunotherapyJournal of Immunotoxicology · 2024
15. Chemotherapy drives tertiary lymphoid structures that correlate with ICI-responsive TCF1+CD8+ T cells in metastatic ovarian cancerClinical Cancer Research · 2024
16. Immune response to cold exposure: Role of γδ T cells and TLR2‐mediated inflammationEuropean Journal of Immunology · 2024
17. DUET-01: A first-in-human, phase 1/2 study of BOXR1030 in patients with advanced glypican-3-positive solid tumors.Journal of Clinical Oncology · 2024
18. Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancerNature Communications · 2024
19. SMAC mimetics overcome apoptotic resistance in ovarian cancer through MSLN-TNF alpha axis2024
20. Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervixTranslational Oncology · 2024